> The University of Massachusetts Lowell has opened a pilot-scale lyophilization facility accessible to outside users. Story
> The Justice Department will defer prosecuting New Jersey-based Rising Pharmaceuticals for price fixing after the company agreed to pay $3 million and cooperate with authorities. Rising’s parent Aceto, which filed for bankruptcy in February, has accused India’s Aurobindo in a lawsuit of sabotaging its business. Story
> Symbiosis Pharmaceutical Services invested $1.9 million to double the size of its site in Scotland, adding 8,000 square feet of manufacturing and administrative space. Story
> U.K.-based drugmaker Hikma is shipping heparin and other drugs to Civica Rx, the hospital-backed company working to mitigate drug shortages. Release
> CDMO Recipharm has a deal to make the injectable Apta-1 drug candidate for biotech Aptahem. Release